Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States

References

• Akbulut S, Sahin TT, Ince V, et al. Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: a case-control study. World J Clin Cases. 2022;10(15):4785–98. doi: 10.12998/wjcc.v10.i15.4785
   PubMed Web of Science ®Google Scholar
• Akbulut S, Garzali IU, Hargura AS, et al. Surveillance, and management of hepatocellular carcinoma during the COVID-19 pandemic: a Narrative Review. J Gastrointest Cancer. 2023;54(2):408–419. doi: 10.1007/s12029-022-00830-2
   PubMed Web of Science ®Google Scholar
• Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: its impact on liver disease and liver transplantation. World J Gastroenterol. 2020;26(22):2987–99. doi: 10.3748/wjg.v26.i22.2987
   PubMed Web of Science ®Google Scholar
• Shiels MS, O’Brien TR. Declining US Hepatocellular Carcinoma Rates, 2014-2017. Clin Gastroenterol Hepatol. 2022;20(2):e330–4. doi: 10.1016/j.cgh.2021.02.011
   PubMed Web of Science ®Google Scholar
• Kim D, Konyn P, Cholankeril G, et al. Decline in annual mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, from 2009 to 2018. Gastroenterology. 2020;159(4):1558–60 e1552. doi: 10.1053/j.gastro.2020.05.007
   PubMed Web of Science ®Google Scholar
• Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(11):1295–1307. doi: 10.1080/17474124.2021.1991792
   PubMed Web of Science ®Google Scholar
• Kim D, Perumpail BJ, Alshuwaykh O, et al. Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019. Liver Int. 2022;42(11):2390–95. doi:10.1111/liv.15381
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi: 10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Munoz-Martinez S, Sapena V, Forner A, et al. Outcome of liver cancer patients with SARS-CoV-2 infection: an international, multicentre, cohort study. Liver Int. 2022;42(8):1891–1901. doi: 10.1111/liv.15320
   PubMed Web of Science ®Google Scholar
• Akbulut S, Bagci N, Akyuz M, et al. Effect of COVID-19 pandemic on patients who have undergone liver transplantation because of hepatocellular carcinoma. Transplant Proc. 2023;55(5):1226–30. doi: 10.1016/j.transproceed.2023.01.038
   PubMed Web of Science ®Google Scholar
• Akbulut S, Yagin FH, Sahin TT, et al. Effect of COVID-19 pandemic on patients who have undergone liver transplantation: retrospective cohort study. J Clin Med. 2023;12(13):4466. doi: 10.3390/jcm12134466
   PubMed Web of Science ®Google Scholar
• P Healthcare Cost & Utilization Project. National inpatients sample. [cited 2023 Feb 1]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp
   Google Scholar
• Myers RP, Quan H, Hubbard JN, et al. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology. 2009;49(2):568–577. doi: 10.1002/hep.22676
   PubMed Web of Science ®Google Scholar
• Kim D, Alshuwaykh O, Dennis BB, et al. Trends in Etiology-based Mortality from Chronic liver disease Before and during COVID-19 pandemic in the United States. Clin Gastroenterol Hepatol. 2022;20(10):2307–16 e2303.
   PubMed Web of Science ®Google Scholar
• Kim D, Li AA, Perumpail BJ, et al. Changing trends in etiology-based and Ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69(3):1064–74. doi: 10.1002/hep.30161
   PubMed Web of Science ®Google Scholar
• Kim D, Manikat R, Cholankeril G, et al. Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021. Liver Int. 2023;43(9):1865–1870.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62(6):1723–30. doi: 10.1002/hep.28123
   PubMed Web of Science ®Google Scholar
• Ahmad FB, Cisewski JA, Minino A, et al. Provisional mortality data - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(14):519–522. doi: 10.15585/mmwr.mm7014e1
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Medical expenditure panel survey: using appropriate price indices for analyses of health care expenditures or income across multiple years. [cited 2023 Feb 1]. Available from: https://meps.ahrq.gov/about_meps/Price_Index.shtml
   Google Scholar
• Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51. doi: 10.1002/(SICI)1097-0258(20000215)19:3<335:AID-SIM336>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Liu B, Du Y, Wu Y, et al. Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011-18: population based study. BMJ. 2021;372(n365). doi: 10.1136/bmj.n365
   Google Scholar
• Restrepo BJ. Obesity prevalence among U.S. Adults during the COVID-19 pandemic. Am J Prev Med. 2022;63(1):102–6. doi: 10.1016/j.amepre.2022.01.012
   PubMed Web of Science ®Google Scholar
• Castaldelli-Maia JM, Segura LE, Martins SS. The concerning increasing trend of alcohol beverage sales in the U.S. during the COVID-19 pandemic. Alcohol. 2021;96:37–42. doi: 10.1016/j.alcohol.2021.06.004
   PubMed Web of Science ®Google Scholar
• Pollard MS, Tucker JS, Green HD Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942. doi: 10.1001/jamanetworkopen.2020.22942
   PubMed Web of Science ®Google Scholar
• Julien J, Ayer T, Tapper EB, et al. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: a modeling study. Hepatology. 2022;75(6):1480–90. doi: 10.1002/hep.32272
   PubMedGoogle Scholar
• Kim D, Cholankeril G, Li AA, et al. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019;39(9):1661–71. doi: 10.1111/liv.14135
   PubMed Web of Science ®Google Scholar
• Mittal S, Sada YH, El-Serag HB, et al. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015;13(3):594–601 e591. doi: 10.1016/j.cgh.2014.08.013
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology. 2006;43(4):682–9. doi: 10.1002/hep.21103
   PubMed Web of Science ®Google Scholar
• Kim D, Adeniji N, Latt N, et al. Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study. Clin Gastroenterol Hepatol. 2021;19(7):1469–79 e1419. doi: 10.1016/j.cgh.2020.09.027
   PubMed Web of Science ®Google Scholar
• Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, et al. The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system. Am J Gastroenterol. 2022;117(4):678–84. doi: 10.14309/ajg.0000000000001615
   PubMed Web of Science ®Google Scholar
• Li D, Jia AY, Zorzi J, et al. Impact of the COVID-19 Pandemic on liver cancer Staging at a multidisciplinary liver cancer clinic. Ann Surg Open. 2022;3(4):e207. doi: 10.1097/AS9.0000000000000207
   PubMedGoogle Scholar